# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Lymphomatoid papulosis

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-4 of 4 results.
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
Status: Recruiting
Last Changed: Sep 06, 2019
First Received: Jul 16, 2018
Disease(s): Mycosis Fungoides, Lymphomatoid Papulosis, Sezary Syndrome
Intervention(s): brentuximab vedotin, brentuximab vedotin, brentuximab vedotin
Locations: Stanford University Medical Center, Stanford, California, United States
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Memorial Sloan Kettering Commack, Commack, New York, United States
... and 4 other locations.
Tissue Repository: CTCL Collection Protocol
Status: Recruiting
Last Changed: Feb 05, 2019
First Received: Jul 21, 2016
Disease(s): Lymphoma, T-Cell, Cutaneous, Lymphomatoid Papulosis, Sézary Syndrome
Locations: Columbia University Medical Center, New York, New York, United States
Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma
Status: Recruiting
Last Changed: Mar 20, 2018
First Received: Jan 24, 2018
Disease(s): Lymphomatoid Papulosis, Primary Cutaneous Anaplastic Large Cell Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Stage I Cutaneous T-Cell Non-Hodgkin Lymphoma, Stage II Cutaneous T-Cell Non-Hodgkin Lymphoma, Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma, Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma
Intervention(s): Brentuximab Vedotin, Laboratory Biomarker Analysis, Lenalidomide
Locations: Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and NHL
Status: Recruiting
Last Changed: Jun 12, 2019
First Received: Jul 26, 2018
Disease(s): Lymphoma, Lymphoma, Non-Hodgkin, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoproliferative Disorders, Neoplasms, Cutaneous Lymphoma, Cutaneous Anaplastic Large Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphomatoid Papulosis
Intervention(s): ATLCAR.CD30.CCR4 cells, ALTCAR.CD30 cells, Bendamustine, Fludarabine
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States